Cosmo Wins Over EMA With Risk Minimizing Measures And Expert Advice For Winlevi

 
• By Neena Brizmohun
  
Hand Pointing At Blue Arrows Going In Opposite Direction
The EMA has reversed its decision and now says that Winlevi should be approved (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU CHMP

More from Product Reviews